Mind Medicine Stock Probability of Future Stock Price Finishing Over 22.81
| MNMD Stock | USD 7.16 0.14 1.99% |
Mind |
Mind Medicine Target Price Odds to finish over 22.81
The tendency of Mind Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 22.81 or more in 90 days |
| 7.16 | 90 days | 22.81 | close to zero percent |
Based on a normal probability distribution, the odds of Mind Medicine to move over $ 22.81 or more in 90 days from now is close to zero percent (This Mind Medicine probability density function shows the probability of Mind Stock to fall within a particular range of prices over 90 days) . Probability of Mind Medicine price to stay between its current price of $ 7.16 and $ 22.81 at the end of the 90-day period is about 30.3 .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.17 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Mind Medicine will likely underperform. Additionally Mind Medicine has an alpha of 0.0389, implying that it can generate a 0.0389 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Mind Medicine Price Density |
| Price |
Predictive Modules for Mind Medicine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mind Medicine. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mind Medicine Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mind Medicine is not an exception. The market had few large corrections towards the Mind Medicine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mind Medicine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mind Medicine within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 3.17 | |
σ | Overall volatility | 0.95 | |
Ir | Information ratio | 0.05 |
Mind Medicine Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mind Medicine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mind Medicine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mind Medicine had very high historical volatility over the last 90 days | |
| Net Loss for the year was (95.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mind Medicine currently holds about 105.74 M in cash with (64.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Mind Medicine has a frail financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: MindMed Scientific Presentations at American College of Neuropsychopharmacology 2024 Congress |
Mind Medicine Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mind Stock often depends not only on the future outlook of the current and potential Mind Medicine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mind Medicine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.2 M | |
| Cash And Short Term Investments | 99.7 M |
Mind Medicine Technical Analysis
Mind Medicine's future price can be derived by breaking down and analyzing its technical indicators over time. Mind Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mind Medicine. In general, you should focus on analyzing Mind Stock price patterns and their correlations with different microeconomic environments and drivers.
Mind Medicine Predictive Forecast Models
Mind Medicine's time-series forecasting models is one of many Mind Medicine's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mind Medicine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mind Medicine
Checking the ongoing alerts about Mind Medicine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mind Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mind Medicine had very high historical volatility over the last 90 days | |
| Net Loss for the year was (95.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mind Medicine currently holds about 105.74 M in cash with (64.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.71. | |
| Mind Medicine has a frail financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: MindMed Scientific Presentations at American College of Neuropsychopharmacology 2024 Congress |
Check out Mind Medicine Backtesting, Mind Medicine Valuation, Mind Medicine Correlation, Mind Medicine Hype Analysis, Mind Medicine Volatility, Mind Medicine History as well as Mind Medicine Performance. For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.71) | Return On Assets (0.25) | Return On Equity (0.55) |
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.